Sipuleucel-T in Metastatic Castration-Resistant Prostate Concert Profile Report

被引：2
|
作者：
Plosker, Greg L. [1 ]
机构：
[1] Adis Int Ltd, Auckland 0754, New Zealand
来源：
BIODRUGS | 2011年 / 25卷 / 04期
关键词：
CANCER; IMMUNOTHERAPY; MITOXANTRONE; PREDNISONE; DOCETAXEL;
D O I：
10.2165/11207140-000000000-00000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [11] Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
    Yi, Renliang
    Chen, Baoxin
    Duan, Peng
    Zheng, Chanjiao
    Shen, Huanyu
    Liu, Qun
    Yuan, Chen
    Ou, Weilin
    Zhou, Zhiheng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [12] The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature
    Sonpavde, Guru
    Di Lorenzo, Giuseppe
    Higano, Celestia S.
    Kantoff, Philip W.
    Madan, Ravi
    Shore, Neal D.
    EUROPEAN UROLOGY, 2012, 61 (04) : 639 - 647
  • [13] Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T
    Aslan, Guven
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (02): : 156 - 158
  • [14] Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
    Higano, Celestia S.
    Armstrong, Andrew J.
    Sartor, A. Oliver
    Vogelzang, Nicholas J.
    Kantoff, Philip W.
    McLeod, David G.
    Pieczonka, Christopher M.
    Penson, David F.
    Shore, Neal D.
    Vacirca, Jeffrey
    Concepcion, Raoul S.
    Tutrone, Ronald F.
    Nordquist, Luke T.
    Quinn, David I.
    Kassabian, Vahan
    Scholz, Mark C.
    Harmon, Matt
    Tyler, Robert C.
    Chang, Nancy N.
    Tang, Hong
    Cooperberg, Matthew R.
    CANCER, 2019, 125 (23) : 4172 - 4180
  • [15] Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine
    Wargowski, Ellen
    Johnson, Laura E.
    Eickhoff, Jens C.
    Delmastro, Lauren
    Staab, Mary Jane
    Liu, Glenn
    McNeel, Douglas G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [16] Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
    Holl, Eda K.
    McNamara, Megan A.
    Healy, Patrick
    Anand, Monika
    Concepcion, Raoul S.
    Breland, Coleman D.
    Dumbudze, Igor
    Tutrone, Ron
    Shore, Neal
    Armstrong, Andrew J.
    Harrison, Michael
    Wallace, Joe A.
    Wu, Yuan
    George, Daniel J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 588 - 592
  • [17] Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T?
    Lue, Chen
    Williams, Andrew K.
    Chalasani, Venu
    Martinez, Carlos H.
    Chin, Joseph
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (01) : 99 - 108
  • [18] Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials
    Antonarakis, Emmanuel S.
    Subudhi, Sumit K.
    Pieczonka, Christopher M.
    Karsh, Lawrence I.
    Quinn, David I.
    Hafron, Jason M.
    Wilfehrt, Helen M.
    Harmon, Matthew
    Sheikh, Nadeem A.
    Shore, Neal D.
    Petrylak, Daniel P.
    CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2426 - 2434
  • [19] Sipuleucel-TIn Metastatic Castration-Resistant Prostate Cancer
    Greg L. Plosker
    Drugs, 2011, 71 : 101 - 108
  • [20] Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T
    McNamara, Megan
    Berry, William
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : E361 - E364
12345